Skip to main content

Glycobiology Market | Global Market Share, Size and Growth Analysis

The global glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. Glycobiology is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycobiology products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets.

Glycobiology Market Dynamics

Drivers

  • Increasing funding for proteomics & glycomics research and growing R&D expenditure
  • Growth of the proteomics market
  • Technological advancements in glycomics instrumentation

Restraints

  • High degree of consolidation acts as an entry barrier for new entrants
  • Stringent regulatory frameworks and time-consuming approval processes

Opportunities

  • Increased use of personalized medicine
  • Biomarkers identification
  • Developing countries and emerging markets

The following are the major objectives of the study.

  • To define, describe, and forecast the global glycobiology market on the basis of product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the glycobiology market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall Glycobiology market
  • To analyze the opportunities in the market for stakeholders and to provide details of the competitive landscape for market leaders
  • To forecast the Glycobiology market size of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies2
  • To track and analyze the competitive developments such as new product launches, agreements, collaborations, acquisitions, expansion and agreements in the glycomics market

Comments

Popular posts from this blog

Smoke Evacuation Systems Market: Renewed Growth Opportunities Owing to the Increasing Number of Elective Procedures

  Which are The Key Factors Driving Growth in Smoke Evacuation System Market? Factors such increased product availability of smoke evacuation systems, rising patient preference for minimally invasive surgeries, expansion in the target patient population, and wider acceptance and availability of relevant operating room protocols and guidelines for smoke evacuation systems are the major factors driving the growth of the global smoke evacuation system market. How The Smoke Evacuation Industry Will Grow in Coming Years? The surgical smoke evacuation system market is estimated to grow at a CAGR of 6.6% to reach USD 154 million by 2025 from USD 115 million in 2020. Emerging countries and increasing number of elective surgical procedures. Emerging countries (such as China, India, South Korea, Brazil, and Mexico) offer significant growth opportunities to players operating in the global smoke evacuation systems market. This can be attributed to the increasing public and private i...

Illumina (US), Thermo Fisher (US), and QIAGEN (Netherlands)—Major Players in the Global Epigenetics Market

The global epigenetics market is projected to reach USD 1,605.7 Million by 2022 from USD 854.0 Million in 2017, at a CAGR of 13.5% from 2017 to 2022. Favorable government funding initiatives for epigenetics research, increasing research activities, decreasing sequencing costs & time, and rising prevalence of cancer are the key factors driving market growth Key players in the global epigenetics market, such as Illumina, Thermo Fisher, Diagenode, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, and PerkinElmer, are focusing on increasing their presence in the high-growth markets through organic as well as inorganic strategies such as product launches, partnerships, agreements, collaborations, expansions, and acquisitions. http://www.marketsandmarkets.com/ResearchInsight/epigenetics-technologies-market.asp Illumina dominated the global epigenetics market in 2016. The company provides sequencing and array-based solutions for ge...

Best Accounting Software to Kick-start the Business for Smaller Firms – Xero

  Xero Accounting Software is an online software mainly designed for the accounting needs of small business firms. The software can be operated from a PC, phone, tablet, or Mac to view the cash flows of the company in real-time. The software is for small business houses and hence it is simple to use yet smart so that the users can devote most of the time in other important areas of their business. USP of This Software: Xero accounting software offers accounting services to small business firms in a smarter way. Some of the USPs of the software the more than 800apps integrated into the software, secure encryption, support system better performance report generation, and others apart from the basic accounting services offered. Best Accounting Software for Medium-Sized Businesses@ https://blog.360quadrants.com/2020/best-accounting-software-for-medium-sized-businesses/ Xero Pricing Xero accounting software offers 30 days of free trial after which you can choose from any of the pri...